Status:
UNKNOWN
Hip DAA Closure Techniques
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Total Hip Replacement
Wound Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to analyze the difference in rates of wound complications using two different closure techniques in Direct anterior approach for primary total hip replacement.
Detailed Description
The use of the direct anterior approach (DAA) for primary total hip arthroplasty (THA) has been increasingly popular but there has been a reported increased risk of wound complications compared with a...
Eligibility Criteria
Inclusion
- Patients older than 18 years old that will undergo THA via DAA
Exclusion
- Previous hip arthroplasty surgeries or scars
- THA secondary to oncologic or traumatic etiologies
- BMI ≥ 40
- uncontrolled diabetes (measured by a Hgb A1c above 8)
- reported allergy to skin adhesive
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2024
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT06006572
Start Date
March 1 2023
End Date
October 30 2024
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107